Skip to contentEASTHAM KARIN — ILLUMINA INC insider: 413 transactions · InsiderLensEASTHAM KARIN
- Director at SGX PHARMACEUTICALS, INC. · on record since Jan 31, 2006
- Director at AMYLIN PHARMACEUTICALS INC · on record since Feb 14, 2006
- Director at TERCICA INC · on record since Jun 16, 2006
- Director at VERACYTE, INC. · on record since Oct 29, 2013
- Director at ILLUMINA INC · on record since Jun 9, 2006
- Director at GENOPTIX INC · on record since Aug 1, 2008
- Sr. VP Finance, CFO & Sec. at DIVERSA CORP · on record since May 3, 2004
- Director at GERON CORP · on record since Apr 2, 2009
- Director at Trius Therapeutics Inc · on record since Aug 10, 2010
- Director at Personalis, Inc. · on record since May 14, 2026
- Director at NEKTAR THERAPEUTICS · on record since Oct 1, 2018
Insider trading activity of EASTHAM KARIN
- Transactions on record
- 413
- since Jan 13, 2004
- Open-market buys
- 0
- Open-market sells
- 131
- $169.6M
- Companies traded
- 11
- last filing Jun 22, 2026
Figures computed from official regulatory filings — methodology.
Companies where EASTHAM KARIN has traded
- VERACYTE, INC.68 tx · $151.1M · Jun 22, 2026
- Personalis, Inc.12 tx · Jun 11, 2026
- GERON CORP34 tx · $185.7K · Jan 17, 2023
- NEKTAR THERAPEUTICS13 tx · $76.8K · Sep 20, 2022
- ILLUMINA INC153 tx · $26M · May 28, 2019
- Trius Therapeutics Inc14 tx · $487.7K · Sep 13, 2013
- AMYLIN PHARMACEUTICALS INC38 tx · $4.1M · Aug 10, 2012
- GENOPTIX INC14 tx · $252.6K · Mar 7, 2011
- TERCICA INC12 tx · $444.7K · Oct 20, 2008
- SGX PHARMACEUTICALS, INC.
Track record of EASTHAM KARIN
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of EASTHAM KARIN
Co-insiders of EASTHAM KARIN
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $54K · Aug 21, 2008
EPSTEIN ROBERT SILLUMINA INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 22, 2026 | Sell | -3,200 | 52.78 USD | — | SEC |
| Jun 22, 2026 | Sell | -529 | 53.55 USD | — | SEC |
| Jun 15, 2026 | Award | 5,272 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | Award | 6,250 | 0.00 USD | $0 | SEC |
| May 14, 2026 | Award | 6,250 | 0.00 USD | $0 | SEC |
| May 14, 2026 | AwardD | 37,500 | 0.00 USD | $0 | SEC |
| Dec 8, 2025 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Dec 8, 2025 | Exercise | 10,000 | 7.94 USD | $79.4K | SEC |
| Dec 8, 2025 | Sell | -6,392 | 44.52 USD | $284.6K | SEC |
| Dec 8, 2025 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Dec 8, 2025 | Sell | -12,808 | 45.84 USD | $587.1K | SEC |
| Dec 8, 2025 | Sell | -800 | 46.59 USD | $37.3K | SEC |
| Dec 8, 2025 | Exercise | 10,000 | 7.60 USD | $76K | SEC |
| Nov 7, 2025 | Sell | -9,674 | 40.02 USD | $387.2K | SEC |
| Jun 23, 2025 | Award | 9,321 | 0.00 USD | $0 | SEC |
| Jun 17, 2025 | Sell | -4,590 | 26.66 USD | $122.4K | SEC |
| May 20, 2025 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | Sell | -5,309 | 40.12 USD | $213K | SEC |
| Jan 6, 2025 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2025 | Sell | -4,691 | 40.50 USD | $190K | SEC |
| Jan 6, 2025 | Exercise | 10,000 | 5.28 USD | $52.8K | SEC |
| Nov 21, 2024 | Sell | -10,125 | 38.76 USD | $392.4K | SEC |
| Nov 21, 2024 | Sell | -1,600 | 36.77 USD | $58.8K | SEC |
| Nov 21, 2024 | Sell | -3,006 | 37.77 USD | $113.5K | SEC |
| Jul 18, 2024 | Sell | -7,500 | 25.00 USD | $187.5K | SEC |